Cambridge Cognition (COG) Competitors

GBX 35 0.00 (0.00%)

As of 05/15/2026 05:26 AM Eastern

COG vs. KOO, INHC, RENX, FDBK, and IQAI

Should you buy Cambridge Cognition stock or one of its competitors? MarketBeat compares Cambridge Cognition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cambridge Cognition include Kooth (KOO), Induction Healthcare Group (INHC), Renalytix (RENX), Feedback (FDBK), and IQ-AI (IQAI). These companies are all part of the "health information services" industry.

How does Cambridge Cognition compare to Kooth?

Cambridge Cognition (LON:COG) and Kooth (LON:KOO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

15.9% of Cambridge Cognition shares are owned by institutional investors. Comparatively, 21.7% of Kooth shares are owned by institutional investors. 3.4% of Cambridge Cognition shares are owned by company insiders. Comparatively, 30.6% of Kooth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cambridge Cognition	£9.40M	1.73	-£1.58M	-£3.90	N/A
Kooth	£63.29M	0.80	£4.00M	£7.00	20.00

In the previous week, Cambridge Cognition and Cambridge Cognition both had 2 articles in the media. Kooth's average media sentiment score of 0.51 beat Cambridge Cognition's score of 0.00 indicating that Kooth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cambridge Cognition	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Kooth	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Kooth has a net margin of 4.12% compared to Cambridge Cognition's net margin of -17.82%. Kooth's return on equity of 8.84% beat Cambridge Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cambridge Cognition	-17.82%	-62.89%	-0.30%
Kooth	4.12%	8.84%	10.12%

Cambridge Cognition currently has a consensus target price of GBX 56, indicating a potential upside of 60.00%. Kooth has a consensus target price of GBX 330, indicating a potential upside of 135.71%. Given Kooth's higher probable upside, analysts clearly believe Kooth is more favorable than Cambridge Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Kooth	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Cambridge Cognition has a beta of 0.832, indicating that its share price is 17% less volatile than the broader market. Comparatively, Kooth has a beta of 1.238, indicating that its share price is 24% more volatile than the broader market.

Summary

Kooth beats Cambridge Cognition on 13 of the 14 factors compared between the two stocks.

How does Cambridge Cognition compare to Induction Healthcare Group?

Induction Healthcare Group (LON:INHC) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Cambridge Cognition has a consensus target price of GBX 56, suggesting a potential upside of 60.00%. Given Cambridge Cognition's stronger consensus rating and higher probable upside, analysts clearly believe Cambridge Cognition is more favorable than Induction Healthcare Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Induction Healthcare Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Cambridge Cognition has lower revenue, but higher earnings than Induction Healthcare Group. Cambridge Cognition is trading at a lower price-to-earnings ratio than Induction Healthcare Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Induction Healthcare Group	£12.57M	0.72	-£5.12M	-£5.54	N/A
Cambridge Cognition	£9.40M	1.73	-£1.58M	-£3.90	N/A

In the previous week, Cambridge Cognition had 2 more articles in the media than Induction Healthcare Group. MarketBeat recorded 2 mentions for Cambridge Cognition and 0 mentions for Induction Healthcare Group. Induction Healthcare Group's average media sentiment score of 0.00 equaled Cambridge Cognition'saverage media sentiment score.

Company	Overall Sentiment
Induction Healthcare Group	Neutral
Cambridge Cognition	Neutral

46.3% of Induction Healthcare Group shares are owned by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are owned by institutional investors. 54.6% of Induction Healthcare Group shares are owned by insiders. Comparatively, 3.4% of Cambridge Cognition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cambridge Cognition has a net margin of -17.82% compared to Induction Healthcare Group's net margin of -23.86%. Induction Healthcare Group's return on equity of -14.58% beat Cambridge Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Induction Healthcare Group	-23.86%	-14.58%	-7.32%
Cambridge Cognition	-17.82%	-62.89%	-0.30%

Induction Healthcare Group has a beta of -0.41, meaning that its stock price is 141% less volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.832, meaning that its stock price is 17% less volatile than the broader market.

Summary

Cambridge Cognition beats Induction Healthcare Group on 10 of the 15 factors compared between the two stocks.

How does Cambridge Cognition compare to Renalytix?

Renalytix (LON:RENX) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Renalytix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Cambridge Cognition has higher revenue and earnings than Renalytix. Cambridge Cognition is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Renalytix	£3.30M	2.13	-£109.93M	-£4.00	N/A
Cambridge Cognition	£9.40M	1.73	-£1.58M	-£3.90	N/A

In the previous week, Cambridge Cognition had 1 more articles in the media than Renalytix. MarketBeat recorded 2 mentions for Cambridge Cognition and 1 mentions for Renalytix. Cambridge Cognition's average media sentiment score of 0.00 beat Renalytix's score of -1.02 indicating that Cambridge Cognition is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Renalytix	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative
Cambridge Cognition	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

14.0% of Renalytix shares are owned by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are owned by institutional investors. 5.1% of Renalytix shares are owned by insiders. Comparatively, 3.4% of Cambridge Cognition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Renalytix has a beta of 1.974, meaning that its stock price is 97% more volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.832, meaning that its stock price is 17% less volatile than the broader market.

Cambridge Cognition has a net margin of -17.82% compared to Renalytix's net margin of -680.00%. Renalytix's return on equity of 274.67% beat Cambridge Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Renalytix	-680.00%	274.67%	-93.54%
Cambridge Cognition	-17.82%	-62.89%	-0.30%

Summary

Cambridge Cognition beats Renalytix on 11 of the 16 factors compared between the two stocks.

How does Cambridge Cognition compare to Feedback?

Feedback (LON:FDBK) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Cambridge Cognition has higher revenue and earnings than Feedback. Cambridge Cognition is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Feedback	£849.62K	4.64	-£10.84M	-£15.74	N/A
Cambridge Cognition	£9.40M	1.73	-£1.58M	-£3.90	N/A

Feedback has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.832, indicating that its share price is 17% less volatile than the broader market.

35.7% of Feedback shares are owned by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are owned by institutional investors. 8.0% of Feedback shares are owned by insiders. Comparatively, 3.4% of Cambridge Cognition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cambridge Cognition has a consensus target price of GBX 56, suggesting a potential upside of 60.00%. Given Cambridge Cognition's stronger consensus rating and higher possible upside, analysts plainly believe Cambridge Cognition is more favorable than Feedback.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Feedback	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Cambridge Cognition had 1 more articles in the media than Feedback. MarketBeat recorded 2 mentions for Cambridge Cognition and 1 mentions for Feedback. Feedback's average media sentiment score of 0.00 equaled Cambridge Cognition'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Feedback	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cambridge Cognition	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cambridge Cognition has a net margin of -17.82% compared to Feedback's net margin of -845.25%. Cambridge Cognition's return on equity of -62.89% beat Feedback's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Feedback	-845.25%	-135.17%	-22.99%
Cambridge Cognition	-17.82%	-62.89%	-0.30%

Summary

Cambridge Cognition beats Feedback on 11 of the 15 factors compared between the two stocks.

How does Cambridge Cognition compare to IQ-AI?

Cambridge Cognition (LON:COG) and IQ-AI (LON:IQAI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Cambridge Cognition presently has a consensus target price of GBX 56, suggesting a potential upside of 60.00%. Given Cambridge Cognition's stronger consensus rating and higher probable upside, analysts clearly believe Cambridge Cognition is more favorable than IQ-AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
IQ-AI	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Cambridge Cognition has a net margin of -17.82% compared to IQ-AI's net margin of -77.52%. Cambridge Cognition's return on equity of -62.89% beat IQ-AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cambridge Cognition	-17.82%	-62.89%	-0.30%
IQ-AI	-77.52%	-140.75%	-22.03%

15.9% of Cambridge Cognition shares are held by institutional investors. 3.4% of Cambridge Cognition shares are held by company insiders. Comparatively, 66.0% of IQ-AI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cambridge Cognition has a beta of 0.832, indicating that its share price is 17% less volatile than the broader market. Comparatively, IQ-AI has a beta of 2.25, indicating that its share price is 125% more volatile than the broader market.

IQ-AI has lower revenue, but higher earnings than Cambridge Cognition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cambridge Cognition	£9.40M	1.73	-£1.58M	-£3.90	N/A
IQ-AI	£538.19K	3.30	N/A	N/A	N/A

In the previous week, Cambridge Cognition had 2 more articles in the media than IQ-AI. MarketBeat recorded 2 mentions for Cambridge Cognition and 0 mentions for IQ-AI. Cambridge Cognition's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score.

Company	Overall Sentiment
Cambridge Cognition	Neutral
IQ-AI	Neutral

Summary

Cambridge Cognition beats IQ-AI on 10 of the 13 factors compared between the two stocks.

Get Cambridge Cognition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COG vs. The Competition

Export

Metric	Cambridge Cognition	Health Information Services Industry	Medical Sector	LON Exchange
Market Cap	£16.29M	£318.05M	£6.33B	£2.74B
Dividend Yield	N/A	5.59%	2.80%	6.07%
P/E Ratio	-8.97	179.62	20.29	365.91
Price / Sales	1.73	122.94	547.55	88,016.94
Price / Cash	4.31	47.14	43.04	27.89
Price / Book	4.82	5.29	9.83	7.74
Net Income	-£1.58M	-£22.78M	£3.56B	£5.89B
7 Day Performance	N/A	-1.12%	0.26%	0.25%
1 Month Performance	-7.53%	-5.24%	-1.30%	1.56%
1 Year Performance	-10.26%	-12.62%	33.62%	85.82%

Cambridge Cognition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COG Cambridge Cognition	1.1717 of 5 stars	GBX 35 flat	GBX 56 +60.0%	-7.9%	£16.29M	£9.40M	N/A	80	News Coverage Gap Down High Trading Volume
KOO Kooth	2.8995 of 5 stars	GBX 134.25 +0.2%	GBX 330 +145.8%	+4.6%	£48.69M	£63.29M	19.18	478
INHC Induction Healthcare Group	N/A	GBX 9.75 flat	N/A	+5.2%	£9.00M	£12.57M	N/A	74
RENX Renalytix	N/A	GBX 1.61 -19.8%	N/A	-80.0%	£7.01M	£3.30M	N/A	102	Gap Down
FDBK Feedback	N/A	GBX 9.25 flat	N/A	-33.6%	£4.05M	£849.62K	N/A	24	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:COG) was last updated on 5/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cambridge Cognition (COG) Competitors

COG vs. KOO, INHC, RENX, FDBK, and IQAI

How does Cambridge Cognition compare to Kooth?

Summary

How does Cambridge Cognition compare to Induction Healthcare Group?

Summary

How does Cambridge Cognition compare to Renalytix?

Summary

How does Cambridge Cognition compare to Feedback?

Summary

How does Cambridge Cognition compare to IQ-AI?

Summary

Media Sentiment Over Time

COG vs. The Competition

Cambridge Cognition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cambridge Cognition (COG) Competitors

COG vs. KOO, INHC, RENX, FDBK, and IQAI

How does Cambridge Cognition compare to Kooth?

Do insiders & institutionals hold more shares of COG or KOO?

Which has higher earnings & valuation, COG or KOO?

Does the media refer more to COG or KOO?

Is COG or KOO more profitable?

Do analysts rate COG or KOO?

Which has more volatility & risk, COG or KOO?

Summary

How does Cambridge Cognition compare to Induction Healthcare Group?

Do analysts recommend INHC or COG?

Which has better earnings and valuation, INHC or COG?

Does the media refer more to INHC or COG?

Do insiders & institutionals have more ownership in INHC or COG?

Is INHC or COG more profitable?

Which has more volatility and risk, INHC or COG?

Summary

How does Cambridge Cognition compare to Renalytix?

Do analysts recommend RENX or COG?

Which has better earnings and valuation, RENX or COG?

Does the media refer more to RENX or COG?

Do insiders & institutionals have more ownership in RENX or COG?

Which has more volatility and risk, RENX or COG?

Is RENX or COG more profitable?

Summary

How does Cambridge Cognition compare to Feedback?

Which has preferable valuation & earnings, FDBK or COG?

Which has more risk and volatility, FDBK or COG?

Do institutionals & insiders have more ownership in FDBK or COG?

Do analysts prefer FDBK or COG?

Does the media prefer FDBK or COG?

Is FDBK or COG more profitable?

Summary

How does Cambridge Cognition compare to IQ-AI?

Do analysts prefer COG or IQAI?

Is COG or IQAI more profitable?

Do institutionals and insiders have more ownership in COG or IQAI?

Which has more risk & volatility, COG or IQAI?

Which has preferable valuation & earnings, COG or IQAI?

Does the media prefer COG or IQAI?

Summary

Media Sentiment Over Time

COG vs. The Competition

Cambridge Cognition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools